Scott M. Coiante - Jun 3, 2022 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
SVP, Chief Financial Officer, Director
Signature
/s/ Scott M. Coiante
Stock symbol
APRE
Transactions as of
Jun 3, 2022
Transactions value $
-$28,404
Form type
4
Date filed
6/7/2022, 05:02 PM
Previous filing
Mar 14, 2022
Next filing
Aug 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APRE Common Stock Tax liability -$28.4K -35.3K -29.51% $0.81* 84.3K Jun 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 86,067 restricted stock units.